From Medscape Dermatology

Coverage from the

American Academy of Dermatology (AAD) Annual Meeting

March 03 - 07, 2017; Orlando, FL

March 03 - 07, 2017 Orlando, FL

AAD JAK Inhibitors Show Promise for Alopecia, Eczema, Vitiligo A researcher at the forefront shares promising results from small studies. Clinical trials are in progress and he predicts FDA approval for a JAK inhibitor for alopecia and eczema within 3 years.
Medscape Medical News, March 7, 2017
AAD New Biologic is 'Potential Blockbuster' for Eczema Treatment Dupilumab safely and effectively controls the symptoms of moderate to severe eczema over the long-term, 1-year data show. FDA approval of the biologic is expected soon, the lead investigator reports.
Medscape Medical News, March 6, 2017
AAD New Topical for Mild to Moderate Psoriasis in the Works It's been decades since a new topical option has been available for mild-to-moderate psoriasis, but a new agent shows promise in a phase 3 trial presented as a late-breaker at the AAD Annual Meeting.
Medscape Medical News, March 5, 2017

Conference News

AAD Clinical Trial Brings Hope for Prurigo Nodularis Patients
Medscape Medical News, March 10, 2017
AAD Skin Diseases Affect One in Four Americans
Medscape Medical News, March 8, 2017
AAD JAK Inhibitors Show Promise for Alopecia, Eczema, Vitiligo
Medscape Medical News, March 7, 2017
AAD New Biologic is 'Potential Blockbuster' for Eczema Treatment
Medscape Medical News, March 6, 2017

AAD New Topical for Mild to Moderate Psoriasis in the Works
Medscape Medical News, March 5, 2017
AAD Low Vitamin D Concerns Lead to Overtesting and Overtreatment
Medscape Medical News, March 4, 2017
AAD Psoriasis Treatments Among Hot Topics at AAD Meeting
Medscape Medical News, February 27, 2017

Popular News From AAD 2016

Investigational Therapeutic Genital Herpes Vaccine Promising Phase 2 data for a novel immunotherapy for genital herpes showed a significant reduction in viral shedding and lesions, although the reduction in lesions was also seen with placebo.
Medscape Medical News, Mar 5, 2016
Topical Anticholinergic Reduces Underarm Hyperhidrosis An investigational anticholinergic gel noninvasively reduces excess sweating with minimal adverse effects, a phase 2b study suggests.
Medscape Medical News, Mar 9, 2016
Cord-Cutting Technique Smooths Cellulite for 3 Years A one-time subcision treatment, in which fibrous septae underlying the characteristic cellulite dimples are cut, is effective and safe, 3-year data show.
Medscape Medical News, Mar 11, 2016

Medscape Dermatology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage